Exactly!And why approve the revised bid before the company was independently valued?Taken on the cheap .. in my opinion (unless a superior offer is received of course).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025